Above all, these results showed that blocking miR-15b-5p promotes CRC tumorigenesis by elevating PD-L1 levels and that overexpressing miR-15b-5p sensitizes tumors to anti-PD-1 therapy in murine models. Here, CD274 is linked to colorectal carcinoma.